Cite
HARVARD Citation
Duerr, M. et al. (n.d.). 306 Functional characterization and nonclinical similarity assessment comparing the biosimilar candidate GP2019 to bevacizumab. European journal of cancer. pp. S56-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Duerr, M. et al. (n.d.). 306 Functional characterization and nonclinical similarity assessment comparing the biosimilar candidate GP2019 to bevacizumab. European journal of cancer. pp. S56-. [Online].